Improvement in Surgery Outcomes for Tricuspid Regurgitation
Author Information
Author(s): Chavez-Ponce Alejandra MD, El Shaer Ahmed MBBS, Samimi Sahar MD, Alarouri Hasan MD, Sulaiman Samian MD, Harris Alyssa MPH, Alkhouli Mohamad MD
Primary Institution: Mayo Clinic
Hypothesis
The growing interest in tricuspid regurgitation is associated with increasing surgical treatment utilization and improved outcomes over time.
Conclusion
The short-term outcomes of isolated tricuspid regurgitation surgery improved between 2016 and 2021, largely due to a changing risk profile of patients referred for surgery.
Supporting Evidence
- Surgical management of isolated functional tricuspid regurgitation remains infrequent in contemporary U.S. practice.
- The prevalence of major comorbidities among patients referred to tricuspid regurgitation surgery decreased over time.
- In-hospital mortality improved from 8.3% in 2016 to 5.7% in 2021.
Takeaway
Doctors are getting better at helping people with a heart problem called tricuspid regurgitation, and more patients are getting the surgery they need.
Methodology
The study analyzed data from a large consortium database to identify patients undergoing tricuspid regurgitation surgery and assessed trends in in-hospital mortality.
Potential Biases
Potential biases due to the administrative nature of the database and exclusion of patients denied surgery.
Limitations
The study is retrospective, relies on administrative data, and lacks detailed information on tricuspid regurgitation.
Participant Demographics
Mean age was 55.1 years, with 50.3% female.
Statistical Information
P-Value
<0.001
Confidence Interval
1.02-1.04
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website